The findings of this genetic association study suggest that UGT1A1 and PNPLA3 were associated with increased risk of hyperbilirubinemia and elevated ALT and AST levels in independent multinational and ancestrally diverse cohorts treated for ALL. The gene discussed is GPT; the disease is Hyperbilirubinemia.